The complex epidemiology of Carbapenem-Resistant enterobacter infections: A multicenter descriptive analysis

Infection Control and Hospital Epidemiology

Volumn 36, Issue 11, 2015, Pages 1283-1291

  Lazarovitch, Tsilia ^a   Amity, Keren ^a   Coyle, Joseph R ^b   Ackerman, Benjamin ^a   Tal Jasper, Ruthy ^c   Ofer Friedman, Hadas ^b   Hayakawa, Kayoko ^d   Bogan, Christopher ^d   Lephart, Paul R ^d   Kaplansky, Tamir ^a   Maskit, Moran ^a   Azouri, Tal ^a   Zaidenstein, Ronit ^a   Perez, Federico ^e   Bonomo, Robert A ^e,f   Kaye, Keith S ^d   Marchaim, Dror ^a,c  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CARBAPENEM; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; TOBRAMYCIN; ANTIINFECTIVE AGENT; BACTERIAL DNA; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CAUSE OF DEATH; CLINICAL FEATURE; CONTROLLED STUDY; ENDEMIC DISEASE; ENTEROBACTERIACEAE INFECTION; EPIDEMIOLOGICAL DATA; ESCHERICHIA COLI; FEMALE; GENETIC ANALYSIS; HOSPITAL CARE; HUMAN; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MODIFIED HODGE TEST; MOLECULAR EPIDEMIOLOGY; MULTICENTER STUDY; NEWBORN; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; WOUND INFECTION; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; ENTEROBACTER; ENTEROBACTERIACEAE INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; ISRAEL; KAPLAN MEIER METHOD; LENGTH OF STAY; MICHIGAN; MICROBIAL SENSITIVITY TEST; MIDDLE AGED; MULTIVARIATE ANALYSIS; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARBAPENEMS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROBACTER; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; ISRAEL; KAPLAN-MEIER ESTIMATE; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; LOGISTIC MODELS; MALE; MICHIGAN; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84958528045     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.186     Document Type: Article

References (43)

1. Sievert DMP, Ricks PP, JRMS Edwards, et al. Antimicrobialresistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 2013;34:1–14.
2. Peleg AY, Hooper DC. Hospital-acquired infections due to gramnegative bacteria. N Engl J Med 2010;362:1804–1813.
3. Schwaber MJ, Graham CS, Sands BE, Gold HS, Carmeli Y. Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broadspectrum cephalosporin-resistant Enterobacter species. Antimicrob Agents Chemother 2003;47:1882–1886.
4. Marchaim D, Navon-Venezia S, Schwaber MJ, Carmeli Y. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 2008;52: 1413–1418.
5. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep 2009;58:256–260.
6. Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA 2008;300:2911–2913.
7. Schwaber MJ, Lev B, Israeli A, et al. Containment of a countrywide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011;52:848–855.
8. Marchaim D, Chopra T, Bhargava A, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol 2012;33:817–830.
9. Marchaim D, Chopra T, Perez F, et al. Outcomes and genetic relatedness of carbapenem-resistant Enterobacteriaceae at Detroit Medical Center. Infect Control Hosp Epidemiol 2011;32:861–871.
10. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008;52:1028–1033.
11. Bogan C, Kaye KS, Chopra T, et al. Outcomes of carbapenemresistant Enterobacteriaceae isolation: matched analysis. Am J Infect Control 2014;42:612–620.
12. Qureshi ZA, Paterson DL, Peleg AY, et al. Clinical characteristics of bacteraemia caused by extended-spectrum beta-lactamaseproducing Enterobacteriaceae in the era of CTX-M-type and KPC-type beta-lactamases. Clin Microbiol Infect 2012;18:887–893.
13. CLSI. Performance standards for antimibrobial susceptibility testing 19th informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute, 2009, M100-S19.
14. Marchaim D, Bogan C, Lazarovitch T, Kaye KS. Outcomes of carbapenem-resistant Enterobacteriaceae isolation: a casecase- case-control investigation. In Program and abstracts of the Israeli Society of Infectious Diseases Annual Convention 2013. Mitspe-Ramon.
15. Marchaim D, Chopra T, Bogan C, et al. The burden of multidrugresistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities. Am J Infect Control 2012;40:760–765.
16. Marchaim D, Chopra T, Pogue JM, et al. Outbreak of colistinresistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother 2011;55:593–599.
17. Marchaim D, Perez F, Lee J, et al. “Swimming in resistance”: cocolonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa. Am J Infect Control 2012;40:830–835.
18. Marchaim D, Zaidenstein R, Lazarovitch T, Karpuch Y, Ziv T, Weinberger M. Epidemiology of bacteremia episodes in a single center: increase in gram-negative isolates, antibiotics resistance, and patient age. Eur J Clin Microbiol Infect Dis 2008;27: 1045–1051.
19. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296–327.
20. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309–332.
21. European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints. http://www.srga.org/eucastwt/MICTAB/index.html. Accessed August 9, 2015.
22. Endimiani A, Depasquale JM, Forero S, et al. Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 2009;64:1102–1110.
23. Endimiani A, Hujer AM, Perez F, et al. Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother 2009;63:427–437.
24. Adler A, Paikin S, Sterlin Y, et al. A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone. J Clin Microbiol 2012;50:3180–3185.
25. Samra Z, Ofir O, Lishtzinsky Y, Madar-Shapiro L, Bishara J. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 2007;30:525–529.
26. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239.
27. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.
28. Bion JF, Edlin SA, Ramsay G, McCabe S, Ledingham IM. Validation of a prognostic score in critically ill patients undergoing transport. Br Med J (Clin Res Ed) 1985;291:432–434.
29. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged: the index of Adl: a standardized measure of biological and psychosocial function. JAMA 1963;185:914–919.
30. McGrath EJ, Chopra T, Abdel-Haq N, et al. An outbreak of carbapenem-resistant Acinetobacter baumannii infection in a neonatal intensive care unit: investigation and control. Infect Control Hosp Epidemiol 2011;32:34–41.
31. Macharashvili N, Kourbatova E, Butsashvili M, Tsertsvadze T, McNutt LA, Leonard MK. Etiology of neonatal blood stream infections in Tbilisi, Republic of Georgia. Int J Infect Dis 2009;13:499–505.
32. Mahmood A, Karamat KA, Butt T. Neonatal sepsis: high antibiotic resistance of the bacterial pathogens in a neonatal intensive care unit in Karachi. J Pak Med Assoc 2002;52:348–350.
33. Carmeli Y, Grisaru-Soen G, Leavitt A, Schwaber M, Dolberg S, Navon-Venezia S. Imipenem resistant Enterobacter cloacae (IMP R EntC) causing an outbreak in a neonatal intensive care unit (NICU) likely introduced by a family member. In: Program and abstracts of Interscience Conference of Antimicrobial Agents and Chemotherapy; 2006; San Francisco, CA.
34. Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev 2009;22: 161–182.
35. Friedman ND, Kaye KS, Stout JE, et al. Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;137:791–797.
36. Schechner V, Kotlovsky T, Tarabeia J, et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol 2011;32:497–503.
37. Cuzon G, Naas T, Truong H, et al. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis 2010;16:1349–1356.
38. Kitchel B, Rasheed JK, Patel JB, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009;53:3365–3370.
39. Doumith M, Ellington MJ, Livermore DM, Woodford N. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 2009;63:659–667.
40. Adler A, Navon-Venezia S, Moran-Gilad J, Marcos E, Schwartz D, Carmeli Y. Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs. J Clin Microbiol 2011;49: 2239–2242.
41. Brennan BM, Coyle JR, Marchaim D, et al. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan. Infect Control Hosp Epidemiol 2014;35:342–349.
42. Borer A, Saidel-Odes L, Riesenberg K, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 2009;30:972–976.
43. Harris AD. Control group selection is an important but neglected issue in studies of antibiotic resistance. Ann Intern Med 2000;132:925.